Management of the patients with stage I germ cell ovarian tumors
- 作者: Nechushkina I.1,2, Nechushkina V.1, Boychenko E.1,2,3, Susuleva N.1,2
-
隶属关系:
- N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
- Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
- Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- 期: 卷 21, 编号 2 (2019)
- 页面: 37-39
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/33516
- DOI: https://doi.org/10.26442/18151434.2019.2.190226
- ID: 33516
如何引用文章
全文:
详细
作者简介
Innesa Nechushkina
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: ivnechushkina@mail.ru
D. Sci. (Med.), Full Prof. Moscow, Russia
Valentina Nechushkina
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Email: drnechushkina@mail.ru
D. Sci. (Med.) Moscow, Russia
Elena Boychenko
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation; Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: e.i.boychenko@yandex.ru
Cand. Sci. (Med.) Moscow, Russia
Natalia Susuleva
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: susuleva@mail.ru
D. Sci. (Med.) Moscow, Russia
参考
- Lee C.W, Song M.J, Park S.T et al. Residual tumor after the salvage surgery is the major factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institute. W J Surg Oncol 2011; 9: 123-30.
- Lee K.H, Lee I.H, Kim B.G et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84-7.
- O’Connor D.M, Norris H.J. The influence of grade on outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 1994; 13: 283-9.
- Marina N.M, Cushing B, Giller R et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Childrenˈs Cancer Group Intergroup Study. J Clin Oncol 1999; 17 (7): 2137-43.
- Cushing B, Giller R, Albin A et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the Pediatric Oncology Group and the Children’s Cancer Group. Am J Obstet Gynecol 1999; 181 (2): 353-8.
- Calaminus G, Gobel U, Teske C et al. Prognosis and outcome of ovarian germ cell tumors - Final results of the German MAKEI 96 trial. Presented at the 42nd Congress of the International Society of Pediatric Oncology. Boston, MA, October 21-24, 2010.
- Mann J.R, Raafat F, Robinson K et al. The United Kingdom Children’s Cancer Group’ second germ cell tumor study: carboplatin, etoposide and bleomycin are effective treatment for children with malignant extracranial germ cell tumors with acceptable toxicity. J Clin Oncol 2000; 18: 3809-18.
- Patterson D.M., Rustin G.J. Controversies in management of germ cell tumors of the ovary. Curr Opin Oncol 2006; 18 (5): 500-6.
- Li H, Hong W, Zhang R et al. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma. Chin Med J (Engl) 2002; 115 (10): 1496-500.
- Heidenreich A, Pfister D. Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice. Ther Adv Urol 2012; 4: 187-205.
- Нечушкина И.В. Опухоли женских половых органов у детей (клиника, диагностика, лечение). Дис. … д-ра мед. наук. М., 2010.
- Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96-100.
- Jorge S, Jones N.L, Chen L et al. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012. Gynecol Oncol 2016; 142 (2): 261-6.
- Mangili G, Scarfone G, Gadducci A et al. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicenter Italian trial in ovarian cancer (MITO-9). Gynecol Oncol 2010; 119 (1): 48-52.
- Mangili G, Sigismondi C, Gadducci A et al. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer 2011; 21 (8): 1414-21.
- Heinzelbecrer J, Gross-Weege M, Weiss C et al. Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels. J Urol 2014; 192 (2): 593-9.
- Isharwal S, Risk M.C. Management of clinical stage I nonseminomatous germ cell tumors. Expert Rev Anticancer 2014; 14 (9): 1021-32.
- Nastaly P, Ruf C, Becker P et al. Circulating tumor cells in patients with testicular germ cell tumors. Clin Cancer Res 2014; 20 (14): 3830-41.
- Nasioudis D, Frey M.K, Chapman-Davis E et al. Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecol Oncol 2017; S0090-8258 (17): 31370-7.
- Billmire D.F, Cullen J.W, Frederick J.R et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465-70.
- Kumar S, Shah J.P, Bryant C.S et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of ovary. Gynecol Oncol 2008; 110: 125-32.